Literature DB >> 8482985

Ceruletide therapy in action tremor following thalamic hemorrhage.

Y Mano1, T Nakamuro, T Takayanagi, R F Mayer.   

Abstract

Two men, aged 63 and 71 years, developed a gross action tremor and dysesthesias several months after an intracerebral hemorrhage. CT and MRI showed a small hemorrhage in the posterior region of the lateral nucleus of the thalamus in each patient. The tremor occurred on movement, had frequencies of 2.5-4.5 Hz and the amplitude varied depending on the joint position of the limb. Ceruletide (a cholecystokinin analog) 0.8 micrograms/kg i.m. produced a marked reduction in the action tremor and improved motor function. This effect appeared 10-15 min after the injection, and lasted for up to 4 weeks. It is suggested that ceruletide may be of value in the treatment of action tremors following a thalamic lesion.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8482985     DOI: 10.1007/bf00857518

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  6 in total

1.  Biogenic amines and active polypeptides in the skin of Australian amphibians.

Authors:  V Erspamer; M Roseghini; R Endean; A Anastasi
Journal:  Nature       Date:  1966-10-08       Impact factor: 49.962

2.  Acute reduction and long-term improvement of chorea with ceruletide (cholecystokinin analogue).

Authors:  T Hashimoto; N Yanagisawa
Journal:  J Neurol Sci       Date:  1990-12       Impact factor: 3.181

3.  Cholecystokinin in the nucleus of the solitary tract of the rat: evidence for its vagal origin.

Authors:  M Palkovits; J Z Kiss; M C Beinfeld; T H Williams
Journal:  Brain Res       Date:  1982-12-09       Impact factor: 3.252

4.  Biphasic and long-lasting effect of ceruletide on tardive dyskinesia.

Authors:  T Nishikawa; M Tanaka; I Koga; Y Uchida
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

5.  Cholecystokinin octapeptide (CCK-8), ceruletide and analogues of ceruletide: effects on tremors induced by oxotremorine, harmine and ibogaine. A comparison with prolyl-leucylglycine amide (MIF), anti-Parkinsonian drugs and clonazepam.

Authors:  G Zetler
Journal:  Neuropharmacology       Date:  1983-06       Impact factor: 5.250

6.  Antipsychotic effects of ceruletide (caerulein) on chronic schizophrenia.

Authors:  T Moroji; N Watanabe; N Aoki; S Itoh
Journal:  Arch Gen Psychiatry       Date:  1982-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.